Kerry A. Rogers, M.D.

Associate Professor in the Division of HematologyThe Ohio State University Comprehensive Cancer Center

Dr. Rogers is an associate professor in the Division of Hematology at The Ohio State University in Columbus and specializes in chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL). She earned her B.A. from Northwestern University and M.D. from the Chicago Medical School. She completed her residency in Internal Medicine at University of Michigan and fellowship in Hematology and Medical Oncology at OSU where she is currently a faculty member. In addition to caring for patients with CLL and HCL in clinic, she is the principal investigator on multiple investigator-initiated and industry-sponsored clinical trials studying chemotherapy-free combination regimens for CLL utilizing BTKi inhibitors. She also conducts translational research on targeted agents for CLL. Dr. Rogers is also a part of the active HCL research group at OSU. Her other clinical research interests include complications of targeted therapy for CLL, management of Richter’s syndrome, and primary and CLL-associated autoimmune cytopenias.

Education

Fellowship in Hematology & Oncology, The Ohio State University, Columbus, OH
Residency in Internal Medicine, University of Michigan, Ann Arbor, MI
Doctor of Medicine (M.D.), Chicago Medical School, Chicago, IL
Bachelor of Arts (B.A.), Biological Sciences, Northwestern University, Evanston, IL

Certifications

Hematology, American Board of Internal Medicine
Medical Oncology, American Board of Internal Medicine
Internal Medicine, American Board of Internal Medicine

Affiliations

Division of Hematology, The Ohio State University
The Ohio State University Comprehensive Cancer Center

Professional Organizations

Professional Accomplishments

WIMS Buckeye Shining Star, 2024
Board of Trustees Scholarship Award for meritorious achievement in the clinical sciences, 2008
Alpha Omega Alpha National Honor Medical Society, 2008
Pathology Honors, 2006

Disclosures: Board of Directors/Advisory Board: Genentech, Inc., AbbVie, Pharmacyclics, AstraZeneca. Consultant/Independent Social Media Partner: Janssen Pharmaceuticals, BeiGene, LOXO@Lilly, Alpine Immune Sciences. Grant/Research Support: AbbVie, Genentech, Inc., Novartis. (As of 1/2/24)

Leukemia

What to Expect With Chronic Lymphocytic Leukemia

Medically Reviewed: Kerry A. Rogers, M.D.

This slower moving form of cancer comes with its own set of symptoms and challenges.

Leukemia

What to Expect With Chronic Lymphocytic Leukemia

Medically Reviewed: Kerry A. Rogers, M.D.

This slower moving form of cancer comes with its own set of symptoms and challenges.

Leukemia

When You Have Chronic Lymphocytic Leukemia, Stress Matters

Medically Reviewed: Kerry A. Rogers, M.D.

We explore the link between mental health and cancer progression, plus stress-relieving tips you can use.

Leukemia

When You Have Chronic Lymphocytic Leukemia, Stress Matters

Medically Reviewed: Kerry A. Rogers, M.D.

We explore the link between mental health and cancer progression, plus stress-relieving tips you can use.

Leukemia

Leukemia: Everything You Need to Know

Medically Reviewed: Kerry A. Rogers, M.D.

Leukemia is a malignant disorder (a form of cancer) that involves the bone marrow and blood systems. Leukemia results in the uncontrolled growth of abnormal (leukemic) white blood cells.

Leukemia

Leukemia: Everything You Need to Know

Medically Reviewed: Kerry A. Rogers, M.D.

Leukemia is a malignant disorder (a form of cancer) that involves the bone marrow and blood systems. Leukemia results in the uncontrolled growth of abnormal (leukemic) white blood cells.

Leukemia